Related Experiment Videos
Zollinger-Ellison syndrome: a clinical update
Postgraduate Medicine
|July 1, 1980
Summary
Zollinger-Ellison syndrome (ZES) involves gastrin-producing tumors causing excess stomach acid, ulcers, and diarrhea. Diagnosis relies on high gastrin levels, with medical management now an option alongside surgery.
Area of Science:
- Gastroenterology
- Endocrinology
- Oncology
Background:
- Zollinger-Ellison syndrome (ZES) is defined by gastrinomas leading to hypergastrinemia.
- Key features include gastric acid hypersecretion, peptic ulcer disease, and diarrhea.
- ZES can be linked to multiple endocrine neoplasia type 1 (MEN1).
Purpose of the Study:
- To outline the diagnostic criteria for Zollinger-Ellison syndrome.
- To review the traditional and modern management strategies for ZES.
Main Methods:
- Diagnostic confirmation involves clinical presentation, assessment of gastric acid output, and serum gastrin level measurement.
- Provocative testing may be used to confirm characteristic gastrin responses.
- Treatment options discussed include surgery and pharmacotherapy.
Main Results:
- Elevated fasting serum gastrin levels or specific responses to provocative tests confirm ZES.
- Surgical resection of gastrinomas was the standard treatment.
- H2-histamine receptor antagonists, like cimetidine, offer effective medical management, sometimes combined with vagotomy.
Conclusions:
- Zollinger-Ellison syndrome diagnosis is based on clinical suspicion, hypersecretion, and elevated gastrin.
- Medical management with H2-receptor antagonists has become a viable alternative to surgery for many ZES patients.